Why oncology marketing is different
The emotional weight
changes everything.
Marketing any healthcare service requires care. Marketing cancer care requires a fundamentally different emotional register. The patient receiving a cancer diagnosis is experiencing one of the most frightening moments of their life. Content, advertising, and communications that feel promotional or manipulative in this context damage trust irrevocably.
ICG's oncology marketing philosophy: be the clearest, most trustworthy source of information at the moment a patient or family most needs it. Educational content that explains diagnosis, staging, and treatment options, written with genuine clinical depth, serves the oncology patient and builds institutional trust simultaneously. This is not a contradiction — it is the only approach that works sustainably in this specialty.
The practical implication: oncology content quality must be higher than any other specialty. Shallow articles about "cancer symptoms" do not serve patients at this moment. Detailed, specific, clinically accurate content on treatment protocols, what to expect at an oncology consultation, the role of tumour boards, multidisciplinary care — this is what oncology patients and families are searching for, and it is what builds the authority that moves rankings.
Why referral network dominates acquisition
In most elective specialties, digital channels drive 40–70% of new patient volume. In oncology, this reverses: physician referrals — from surgical oncologists to medical oncologists, from gynaecologists suspecting ovarian cancer to gynaecologic oncologists, from GPs to cancer centres — drive 60–75% of inpatient cancer hospital volume.
For cancer hospitals: Digital channels support the referral decision (the referring physician Googles the oncologist they're considering recommending), validate the patient's choice after a referral is received, and capture the minority of patients who self-refer (typically for screening, second opinion, or cancer-adjacent symptom queries).
For oncology specialists: The oncologist's personal brand — their digital presence, publications, and visible sub-specialty expertise — influences both referring physician decisions and post-referral patient validation. A radiation oncologist with 200 LinkedIn followers and 8 Google reviews is invisible in both channels compared to one with a strong digital presence.
The second opinion opportunity
One of the most digitally actionable patient journeys in oncology is the second opinion seeker. A patient who has received a cancer diagnosis and treatment recommendation from one centre and is looking to validate or challenge that recommendation at a different institution.
Second opinion queries have high search volume and high appointment booking intent: "cancer second opinion India," "oncology second opinion [city]," "[cancer type] treatment second opinion." These patients have already accepted their diagnosis and are seeking clinical validation, not education. ICG builds second opinion landing pages for cancer hospital clients as a dedicated conversion pathway.
